prednisone has been researched along with Eczema, Atopic in 35 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Excerpt | Relevance | Reference |
---|---|---|
"Thirty-two patients with mild to extensive alopecia areata, including 16 patients with alopecia totalis or universalis, entered a randomized, controlled trial of a 6-week taper of prednisone followed by either 2% topical minoxidil or vehicle applied three times daily for an additional 14 weeks." | 9.07 | Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. ( Carson, SC; Olsen, EA; Turney, EA, 1992) |
"Thirty-two patients with mild to extensive alopecia areata, including 16 patients with alopecia totalis or universalis, entered a randomized, controlled trial of a 6-week taper of prednisone followed by either 2% topical minoxidil or vehicle applied three times daily for an additional 14 weeks." | 5.07 | Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. ( Carson, SC; Olsen, EA; Turney, EA, 1992) |
" It is not known how antifolate dose and dosing frequency affect efficacy in AD, but a primary mechanism is thought to involve the antifolate-mediated accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR)." | 2.79 | LD-aminopterin in the canine homologue of human atopic dermatitis: a randomized, controlled trial reveals dosing factors affecting optimal therapy. ( Griffin, CE; Kahn, SJ; Messinger, L; Mundell, A; Schuler, AD; Zebala, JA, 2014) |
" The average daily prednisone dosage was 6." | 2.69 | High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. ( Alazard, M; Saxon, A; Speights, D; Stiehm, ER; Wakim, M; Yajima, A, 1998) |
"Daily dosage of oral CSA was 3 to 5 mg/kg and mean duration of treatment was 37 months (range, 22-48 months)." | 2.68 | Systemic cyclosporine A in severe atopic keratoconjunctivitis. ( Hannouche, D; Hoang-Xuan, T; Prisant, O; Robin, H, 1997) |
"Lymphopenia is related to an increased risk of opportunistic infections." | 1.48 | Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs. ( Bakker, DS; Bruijnzeel-Koomen, CAFM; de Bruin-Weller, MS; Garritsen, FM; Leavis, HL; van den Broek, MPH; van der Schaft, J, 2018) |
"Sarcoidosis is a chronic multisystem disease of unknown origin, which is characterized by T-helper-1 (Th1)-mediated immune responses." | 1.37 | The development of Th1-mediated sarcoidosis improves the clinical course of Th2-mediated atopic dermatitis. ( Asano, Y; Miyagaki, T; Ohno, Y; Saeki, H; Sato, S; Shibata, S; Tamaki, K; Tsunemi, Y, 2011) |
"She was diagnosed with eczema herpeticum, an uncommon and potentially life-threatening viral infection that arises in areas of pre-existing dermatosis." | 1.35 | Kaposi varicelliform eruption (eczema herpeticum). ( Colven, R; Kirby, P; Olson, J; Robles, DT, 2008) |
"We suggest that food hypersensitivity should be ruled out in patients with hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis." | 1.35 | Hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis in a toddler with food hypersensitivity. ( Estrada-Reyes, E; Gamboa-Marrufo, JD; Hernnández-Román, MP; Nava-Ocampo, AA; Valencia-Herrera, A, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (34.29) | 18.7374 |
1990's | 4 (11.43) | 18.2507 |
2000's | 6 (17.14) | 29.6817 |
2010's | 11 (31.43) | 24.3611 |
2020's | 2 (5.71) | 2.80 |
Authors | Studies |
---|---|
Perche, PO | 1 |
Cook, MK | 1 |
Feldman, SR | 2 |
Cheirif-Wolosky, O | 1 |
Elizalde-Jiménez, IG | 1 |
Romero, MTG | 1 |
Rutt, VL | 1 |
Reed, KX | 1 |
Liu, X | 1 |
Richard, EG | 1 |
Purcell, SM | 1 |
Bakker, DS | 1 |
Garritsen, FM | 1 |
Leavis, HL | 1 |
van der Schaft, J | 1 |
Bruijnzeel-Koomen, CAFM | 1 |
van den Broek, MPH | 1 |
de Bruin-Weller, MS | 1 |
O'Brien, KF | 1 |
DeKlotz, CMC | 1 |
Silverman, RA | 1 |
Li, J | 1 |
Luo, X | 1 |
Ke, H | 1 |
Liang, L | 1 |
Zebala, JA | 1 |
Mundell, A | 1 |
Messinger, L | 1 |
Griffin, CE | 1 |
Schuler, AD | 1 |
Kahn, SJ | 1 |
Krejci-Manwaring, J | 1 |
McCarty, MA | 1 |
Camacho, F | 1 |
Manuel, J | 1 |
Hartle, J | 1 |
Fleischer, A | 1 |
Olson, J | 1 |
Robles, DT | 1 |
Kirby, P | 1 |
Colven, R | 1 |
Miyagaki, T | 1 |
Asano, Y | 1 |
Shibata, S | 1 |
Ohno, Y | 1 |
Tsunemi, Y | 1 |
Saeki, H | 1 |
Tamaki, K | 1 |
Sato, S | 1 |
Taszkun, I | 2 |
Kovalik, M | 1 |
Pomorski, Z | 1 |
Kozak, M | 1 |
Pomorska, D | 1 |
Szczepanik, M | 1 |
Wilkolek, P | 1 |
Palenik, L | 1 |
Shaw, DJ | 1 |
van den Broek, AH | 1 |
Thoday, KL | 1 |
Sasseville, D | 1 |
Nantel-Battista, M | 1 |
Molinari, R | 1 |
Mathew, SD | 1 |
Matthews, T | 1 |
Battafarano, DF | 1 |
Puya, R | 1 |
Alvarez-López, M | 1 |
Velez, A | 1 |
Casas Asuncion, E | 1 |
Moreno, JC | 1 |
BOURGEOIS-SPINASSE, J | 2 |
REINBERG, A | 2 |
SIDI, E | 2 |
ASRILANT, M | 1 |
KAMINSKY, A | 1 |
SAENZ, JM | 1 |
Willemse, T | 1 |
Wedi, B | 1 |
Estrada-Reyes, E | 1 |
Hernnández-Román, MP | 1 |
Gamboa-Marrufo, JD | 1 |
Valencia-Herrera, A | 1 |
Nava-Ocampo, AA | 1 |
Worm, AM | 1 |
Rossing, N | 1 |
Sonenthal, KR | 1 |
Grammer, LC | 1 |
Patterson, R | 1 |
Hoang-Xuan, T | 1 |
Prisant, O | 1 |
Hannouche, D | 1 |
Robin, H | 1 |
Wakim, M | 1 |
Alazard, M | 1 |
Yajima, A | 1 |
Speights, D | 1 |
Saxon, A | 1 |
Stiehm, ER | 1 |
Wergowske, GL | 1 |
Fisher, AA | 1 |
Nesbitt, GH | 1 |
Olsen, EA | 1 |
Carson, SC | 1 |
Turney, EA | 1 |
Ambrus, JL | 1 |
Stoll, H | 1 |
Halpern, J | 1 |
Klein, E | 1 |
Wolff, HH | 1 |
Kutzner, H | 1 |
Kumar, L | 1 |
Newcomb, RW | 1 |
Ishizaka, K | 1 |
Middleton, E | 1 |
Hornbrook, MM | 1 |
Gunnar, S | 1 |
Johansson, O | 1 |
Juhlin, L | 1 |
Wagner, E | 1 |
Bookman, R | 1 |
Katz, EE | 1 |
Thomas, F | 1 |
Owens, L | 1 |
Thomas, J | 1 |
Wolf, JS | 1 |
Volk, M | 1 |
Mendez, G | 1 |
Lee, HM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease[NCT01981889] | Phase 4 | 53 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 reviews available for prednisone and Eczema, Atopic
Article | Year |
---|---|
Abrocitinib: A New FDA-Approved Drug for Moderate-to-Severe Atopic Dermatitis.
Topics: Adolescent; Biological Products; Cyclosporins; Dermatitis, Atopic; Double-Blind Method; Humans; Immu | 2023 |
Recalcitrant Atopic Keratoconjunctivitis in Children: A Case Report and Literature Review.
Topics: Anti-Inflammatory Agents; Child; Conjunctivitis, Allergic; Dermatitis, Atopic; Humans; Immunosuppres | 2018 |
[Atopic dermatitis in dogs: current knowledge of background and therapeutic possibilities].
Topics: Animals; Anti-Allergic Agents; Dermatitis, Atopic; Dog Diseases; Dogs; Evidence-Based Medicine; Fatt | 2004 |
Urticaria.
Topics: Acute Disease; Anaphylaxis; Angioedema; Chronic Disease; Complement C1 Inhibitor Protein; Dermatitis | 2008 |
5 trials available for prednisone and Eczema, Atopic
Article | Year |
---|---|
LD-aminopterin in the canine homologue of human atopic dermatitis: a randomized, controlled trial reveals dosing factors affecting optimal therapy.
Topics: Administration, Oral; Aminopterin; Animals; Dermatitis, Atopic; Dogs; Drug Administration Schedule; | 2014 |
Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Dermatitis, Atopic; Dermatitis, Contact; | 2008 |
Systemic cyclosporine A in severe atopic keratoconjunctivitis.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Conjunctivitis, Allergic; Cyclosporine; Derma | 1997 |
High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
Topics: Adolescent; Adult; Antibodies; Antigens, CD; B-Lymphocytes; CD40 Antigens; Cells, Cultured; Child; D | 1998 |
Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Alopecia Areata; Child; Dermatit | 1992 |
26 other studies available for prednisone and Eczema, Atopic
Article | Year |
---|---|
Systemic treatment for severe atopic dermatitis in children: a case series.
Topics: Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Mycop | 2022 |
Photosensitive atopic dermatitis exacerbated by UVB exposure.
Topics: Anti-Inflammatory Agents; Dermatitis, Atopic; Diagnosis, Differential; Enzyme Inhibitors; Female; Hu | 2017 |
Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs.
Topics: Administration, Oral; Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dermatitis, Ato | 2018 |
Exogenous Cushing syndrome from an unexpected source of systemic steroids.
Topics: Child; Cushing Syndrome; Dermatitis, Atopic; Glucocorticoids; Humans; Male; Prednisolone; Prednisone | 2018 |
Kaposi varicelliform eruption (eczema herpeticum).
Topics: Acyclovir; Adult; Antiviral Agents; Codeine; Dermatitis, Allergic Contact; Dermatitis, Atopic; Diagn | 2008 |
The development of Th1-mediated sarcoidosis improves the clinical course of Th2-mediated atopic dermatitis.
Topics: Adult; Biopsy; Dermatitis, Atopic; Humans; Male; Prednisone; Sarcoidosis; Th1 Cells; Th2 Cells; Tomo | 2011 |
The evaluation of Canine Atopic Dermatitis Extent and Severity Index (CADESI) test in dogs with atopic dermatitis (AD) treated with cyclosporine or prednisone.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Mal | 2010 |
Evaluation of a human generic formulation of ciclosporin in the treatment of canine atopic dermatitis with in vitro assessment of the functional capacity of phagocytic cells.
Topics: Animals; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Female; Humans; | 2011 |
Multiple contact allergies to benzophenones.
Topics: Benzophenones; Dermatitis, Atopic; Dermatitis, Photoallergic; Dermatologic Agents; Humans; Male; Mid | 2011 |
Systemic vasculitis in a patient with atopic dermatitis, eosinophilia, pulmonary-renal syndrome, and positive myeloperoxidase antibody: a classification conundrum.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antirheumatic Agents; Chronic Dise | 2012 |
Treatment of severe refractory adult atopic dermatitis with ustekinumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis, Atopic; Eczema; | 2012 |
[Delta-1-dehydrocortisone in the treatment of allergic dermatosis].
Topics: Dermatitis; Dermatitis, Atopic; Dermatitis, Contact; Humans; Prednisone | 1956 |
[Delta-1-dehydrocortisone in the treatment of allergic dermatosis].
Topics: Dermatitis; Dermatitis, Atopic; Dermatitis, Contact; Humans; Prednisone | 1956 |
[Delta-1-dehydrocortisone in the treatment of allergic dermatosis].
Topics: Dermatitis; Dermatitis, Atopic; Dermatitis, Contact; Humans; Prednisone | 1956 |
[Delta-1-dehydrocortisone in the treatment of allergic dermatosis].
Topics: Dermatitis; Dermatitis, Atopic; Dermatitis, Contact; Humans; Prednisone | 1956 |
[Therapeutic activity of triamcinolone in atopic dermatitis: comparative trials with prednisone & prednisolone].
Topics: Dermatitis, Atopic; Eczema; Fludrocortisone; Prednisolone; Prednisone; Triamcinolone | 1959 |
Hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis in a toddler with food hypersensitivity.
Topics: Azathioprine; Bone Marrow Examination; Cell Separation; Combined Modality Therapy; Dermatitis, Atopi | 2008 |
Microvascular protein leakage in extensive skin diseases: aspects of the transport mechanisms.
Topics: Adult; Aged; Albumins; Biological Transport; Capillary Permeability; Dermatitis, Atopic; Dermatitis, | 1980 |
Do some patients with atopic dermatitis require long-term oral steroid therapy?
Topics: Administration, Oral; Adult; Child; Dermatitis, Atopic; Drug Administration Schedule; Female; Humans | 1993 |
Treatment-resistant atopic dermatitis.
Topics: Acetates; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antipruritics; Cyclopropanes; Dermatiti | 2001 |
Suppression of reactions to certain cosmetics.
Topics: Aldehydes; Animals; Coloring Agents; Cosmetics; Dermatitis, Atopic; Diamines; Female; Guinea Pigs; H | 1977 |
Canine allergic inhalant dermatitis: a review of 230 cases.
Topics: Allergens; Animals; Dermatitis, Atopic; Desensitization, Immunologic; Dog Diseases; Dogs; Female; Ma | 1978 |
Meclomen potentiates dermatologic effects of steroids.
Topics: Dermatitis, Atopic; Drug Synergism; Drug Therapy, Combination; Humans; Male; Meclofenamic Acid; Midd | 1986 |
[How do I treat dyshidrosiform eruptions?].
Topics: Combined Modality Therapy; Dermatitis, Atopic; Dermatitis, Contact; Foot Dermatoses; Hand Dermatoses | 1986 |
IgE levels in sera of children with asthma.
Topics: Adolescent; Allergens; Asthma; Bronchodilator Agents; Child; Dermatitis, Atopic; Female; gamma-Globu | 1971 |
Immunoglobulin E in "healed" atopic dermatitis and after treatment with corticosteroids and azathioprine.
Topics: Adolescent; Adult; Aged; Azathioprine; Dermatitis, Atopic; Eczema; Female; gamma-Globulins; Humans; | 1970 |
[The behavior of blood eosinophils in infants during clinical treatment of eczema].
Topics: Dermatitis, Atopic; Dermatitis, Seborrheic; Eosinophilia; Humans; Infant; Prednisone | 1969 |
ACTH and steroids: their use in the practice of allergy.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Aged; Angioedema; Asthma; C | 1966 |
Differential effect of immunosuppressive agents on T and B lymphocytes.
Topics: Animals; Antilymphocyte Serum; Azathioprine; B-Lymphocytes; Bacterial Infections; Concanavalin A; De | 1974 |